Microbot medical inc. (MBOT)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenue from product sales

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

271

250

208

-

203

210

271

146

182

184

149

129

72

Revenue from licensing agreements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

30

20

-

82

-

23

-718

324

281

284

-

263

248

644

541

223

234

221

253

244

Revenue from licensing agreements, grants and other

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

23

-

-

52

31

75

18

60

38

372

395

41

49

72

123

171

Cost of product sales

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

85

77

66

-

71

64

71

47

60

52

54

35

24

Gross profit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

239

204

217

-

192

184

572

494

163

181

166

217

219

Research and development

691

877

843

741

587

649

623

747

496

238

339

339

184

1,504

-340

-44

-219

-14,369

15

7,238

6,292

-14,029

4,396

5,839

4,629

4,815

5,184

4,804

4,563

3,516

3,478

3,749

3,938

4,833

4,524

5,053

5,525

5,200

4,858

General and administrative

1,472

1,111

948

804

1,329

1,435

1,130

1,145

1,019

1,326

896

896

1,049

9,179

-305

-74

-66

-4,859

14

2,063

2,689

-6,193

2,065

2,143

2,236

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Selling, general and administrative

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,710

1,581

1,887

2,023

1,636

1,775

1,924

2,290

1,733

2,103

2,075

2,017

2,286

Wind-down expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

38

22

156

154

9

35

28

68

114

75

-

125

Total operating expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9,302

8,981

-

6,461

7,982

6,865

8,469

6,895

6,425

6,474

5,696

5,269

5,534

5,897

7,807

6,326

7,272

7,676

7,218

7,270

Operating loss

-2,163

-1,988

-1,791

-1,545

-1,916

-2,084

-1,753

-1,892

-1,515

8,970

-1,235

-1,235

-1,233

-9,393

-645

118

285

19,177

-29

-9,272

-8,960

20,093

-6,379

-7,959

-6,842

-8,958

-6,656

-6,221

-6,257

-6,155

-5,077

-5,349

-5,325

-7,313

-6,163

-7,090

-7,509

-7,000

-7,051

Financing expenses, net

-42

22

-83

3

-45

-42

-5

-2

33

-

48

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Financing income (expenses), net

-

-

-

-

-

-

-

-

-

-

-2,394

48

74

-16

7

46

-9

-

7

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Realized gain on sale of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

83

-

-

-

Change in fair value of warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-988

347

-

-4,076

3,654

326

-2,827

143

-757

188

-

11,239

-6,205

-

-

-

-

-

-

-

Change in fair value of warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4,941

-

1,697

3,020

1,782

1,227

2,440

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

1

-

2

1

2

2

0

1

6

6

2

2

4

2

3

6

1

10

13

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

146

185

-

311

343

380

381

382

392

10

10

11

14

14

14

16

19

20

22

25

Other income (expense), net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-33

140

-

-7

-15

-15

-0

-10

-14

32

-108

-11

-11

47

2

144

-35

-1

232

12

Total other income (expense), net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

810

-390

-

3,759

-4,011

-720

2,448

-535

352

-159

3,917

-11,259

6,183

-4,903

101

1,828

3,055

1,762

1,448

2,441

Net loss from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,619

-11,970

-7,562

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-144

-57

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-137

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-2,205

-1,870

-1,874

-1,542

-1,961

-2,126

-1,758

-1,894

-1,482

-

-1,187

-1,187

-1,307

-8,571

-652

-164

-276

16,928

-37

-8,461

-9,350

21,285

-2,757

-12,115

-7,620

-6,962

-7,191

-5,868

-6,416

-2,758

-16,336

833

-10,229

-7,211

-4,334

-4,035

-5,747

-5,552

-4,610

Basic and diluted net loss per share from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.04

-0.22

-0.14

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic and diluted net loss per share from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

0.00

0.00

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic and diluted net loss per share

-0.31

-0.42

-0.44

-0.36

-0.48

-0.65

-0.60

-0.66

-0.50

-1.90

-0.45

-0.45

0.04

-5.84

-0.08

-0.01

-0.01

2.73

-0.00

-1.07

-1.62

0.24

-0.04

-0.22

-0.14

-0.12

-0.17

-0.15

-0.17

-0.03

-0.54

0.03

-0.45

-0.48

-0.31

-0.29

-0.42

-0.44

-0.38

Basic and diluted weighted average common shares outstanding

7,154

4,367

4,307

4,307

4,086

3,050

2,947

2,855

2,763

-23,263

2,383

2,383

27,212

-

-

-

-

-

7,541

7,932

5,768

12,573

66,535

55,711

55,343

54,359

41,402

39,661

38,263

37,363

30,168

24,806

22,958

15,259

14,009

13,802

13,679

12,709

11,990